The Latest Cardiac and Vascular News
Long-term analysis from landmark renal denervation trial presented as Late Breaking Clinical Science, published simultaneously in The Lancet Data add to growing body of evidence supporting the durability of the Symplicity blood pressure procedure DUBLIN and BOSTON, Sept. 18, 2022 /PRNewswire/ — Medtronic plc ( NYSE: MDT), a global leader in healthcare technology, today announced long-term results […]
DUBLIN, Sept. 15, 2022 /PRNewswire/ — Medtronic plc (the “Company”) ( NYSE:MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. (“Medtronic Luxco”), has priced an offering (the “Offering”) of €500,000,000 principal amount of 2.625% senior notes due 2025, €1,000,000,000 principal amount of 3.000% senior notes due 2028, €1,000,000,000 principal amount of […]
Partnership reflects commitment to patient safety; BioButton® wearable offers up to 1,440 vital signs measurements daily, monitoring patients transitioning from higher to lower acuity settings Technology complements the Medtronic Patient Monitoring business’ HealthCast™ intelligent patient manager portfolio designed for connectivity, visualization, remote patient monitoring, and now, wearables DUBLIN, Aug. 31, 2022 /PRNewswire/ […]
Acquisition adds mapping and navigation platform to company’s cardiac ablation portfolio and brings an integrated system of diagnostic and therapeutic tools to address a broad spectrum of arrhythmias DUBLIN, Aug. 30, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of […]
Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success DUBLIN and BARCELONA, Spain, Aug. 28, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its investigational EV ICD™ System – a first-of-its-kind defibrillator with the lead […]
Revenue exceeds guidance, with known supply chain challenges impacting results; notable strength in Pacing, Cardiac Surgery, Core Spine in the U.S., and Diabetes in Europe DUBLIN, Aug. 23, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2023, which ended July 29, 2022. Key Highlights GAAP […]
DUBLIN, Aug. 18, 2022 /PRNewswire/ — The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 18, 2022, approved the fiscal year 2023 second quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May […]
Partnership underscores Medtronic’s commitment to investing in innovative technologies that support physicians and patients from diagnosis to treatment CathWorks’ FFRangio® System provides diagnostic and physiologic information through artificial intelligence to potentially disrupt traditional FFR and revolutionize the management of coronary artery disease DUBLIN and KEFAR SAVA, Israel, July 12, 2022 /PRNewswire/ — Medtronic […]
CARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the completion of the first of two closings for its previously disclosed sale of the Company’s […]
Sheba Joins a Small and Exclusive Group Of 15 Leading Medical Centers in Europe Authorized to Provide Training on this Unique Technology RAMAT GAN, Israel – June 22, 2022 – Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the last four years, […]
